Scarica l'app Stockscreener
11.75
0.09%
0.010
Rapt Therapeutics Inc Borsa (RAPT) Ultime notizie
Wall Street Analysts Think Rapt Therapeutics (RAPT) Could Surge 101.02%: Read This Before Placing a Bet - Nasdaq
Will RAPT Therapeutics Inc. outperform tech stocksJuly 2025 Trends & Daily Risk Controlled Trade Plans - thegnnews.com
RAPT Therapeutics Inc. Recovery Likely Here’s What Data ShowsMarket Sentiment Review & Daily Price Action Insights - beatles.ru
How to forecast RAPT Therapeutics Inc. trends using time seriesWeekly Profit Analysis & Growth Focused Investment Plans - Newser
Understanding RAPT Therapeutics Inc.’s price movement2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
RAPT Therapeutics Inc. stock daily chart insightsMarket Volume Report & Low Drawdown Momentum Trade Ideas - Newser
Has RAPT Therapeutics Inc. formed a bullish divergenceTrade Ideas & Safe Capital Preservation Plans - Newser
RAPT Therapeutics Inc. Builds Base for Possible Rebound2025 Analyst Calls & Fast Entry High Yield Tips - beatles.ru
What high frequency data says about RAPT Therapeutics Inc.2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Building trade automation scripts for RAPT Therapeutics Inc.2025 Market Overview & Smart Investment Allocation Insights - Newser
Sentiment analysis tools applied to RAPT Therapeutics Inc.Free Profit Target Stock Opportunity Monitor - Newser
Why RAPT Therapeutics Inc. stock attracts strong analyst attentionLow Cost High Gain Picks - newsyoung.net
RAPT Therapeutics: UBS maintains Neutral, raises PT to $9 from $8. - AInvest
Rapt Therapeutics (RAPT)'s Technical Outlook is Bright After Key Golden Cross - Yahoo Finance
Will RAPT Therapeutics Inc. continue its uptrendSector Rotation and Stock Opportunity Analysis - Newser
Volume spikes in RAPT Therapeutics Inc. stock – what they meanFree Smart Trade Plans With Risk Protection - Newser
Analyzing drawdowns of RAPT Therapeutics Inc. with statistical toolsAlgorithmic Forecast for Swing Trading Picks - Newser
Rapt Therapeutics (NASDAQ:RAPT) Cut to Sell at Wall Street Zen - Defense World
Historical volatility pattern of RAPT Therapeutics Inc. visualizedRisk Aware Trading Ideas with Alert Levels - Newser
Promising Potential of RAPT Therapeutics’ RPT904 Drives Buy Rating - TipRanks
HC Wainwright Issues Positive Forecast for RAPT Earnings - Defense World
Ranking RAPT Therapeutics Inc. among high performing stocks via toolsSmart Swing Picks with Confirmed Signals - Newser
Multi asset correlation models including RAPT Therapeutics Inc.Technical Insight Guide for Safer Trades - Newser
Applying Elliott Wave Theory to RAPT Therapeutics Inc.Buy and Hold Position Summary Review - Newser
Published on: 2025-08-09 04:24:12 - beatles.ru
Using AI based signals to follow RAPT Therapeutics Inc.Stock Entry Point Planner with Volume Spike - Newser
Using Ichimoku Cloud for RAPT Therapeutics Inc. technicalsAlpha Stock Picks with Chart Confirmation - Newser
RAPT Therapeutics Reports Q2 2025 Financial Results: Net Loss of $34.8 Million, Cash and Securities Valued at $169 Million. - AInvest
Full technical analysis of RAPT Therapeutics Inc. stockAlpha Trade Flow With Risk Calibration - Newser
Rapt Therapeutics’ Reverse Stock Split: Potential Pitfalls and Market Challenges - TipRanks
Wells Fargo lowers Rapt Therapeutics stock price target to $38 on model changes - Investing.com Canada
Wells Fargo Maintains RAPT Therapeutics(RAPT.US) With Buy Rating, Cuts Target Price to $38 - 富途牛牛
RAPT Therapeutics Reports Q2 2025 Financial Results - TipRanks
RAPT Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
RAPT Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
0.14%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):